Skip to content
Disclosery

EXANE DERIVATIVES: SEE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on SEE, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 9,167 SEE shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 9,167 shares
    Change vs previous 13F -47 shares

    0.3% of the 13F portfolio, value $529,011.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 9,214 shares
    Change vs previous 13F -4,306 shares

    0.17% of the 13F portfolio, value $616,931.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 13,520 shares
    Change vs previous 13F -1,570 shares

    0.22% of the 13F portfolio, value $912,161.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 15,090 shares
    Change vs previous 13F +7,383 shares

    0.21% of the 13F portfolio, value $826,751.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 7,707 shares
    Change vs previous 13F -15,356 shares

    0.1% of the 13F portfolio, value $437,979.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 23,063 shares
    Change vs previous 13F +13,134 shares

    0.32% of the 13F portfolio, value $1,056,700.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 9,929 shares
    Change vs previous 13F +9,883 shares

    0.14% of the 13F portfolio, value $454,628.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 46 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $1,785.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).